HCA Healthcare, Inc. (HCA)
NYSE: HCA · IEX Real-Time Price · USD
297.00
-14.03 (-4.51%)
At close: Apr 18, 2024, 4:00 PM
297.97
+0.97 (0.33%)
After-hours: Apr 18, 2024, 7:28 PM EDT

Company Description

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.

It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.

In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services.

The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare, Inc.
HCA Healthcare logo
Country United States
Founded 1968
Industry Medical Care Facilities
Sector Healthcare
Employees 310,000
CEO Samuel N. Hazen

Contact Details

Address:
One Park Plz
Nashville, Tennessee 37203
United States
Phone (615) 344-9551
Website hcahealthcare.com

Stock Details

Ticker Symbol HCA
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000860730
CUSIP Number 40412C101
ISIN Number US40412C1018
Employer ID 27-3865930
SIC Code 8062

Key Executives

Name Position
Samuel N. Hazen Chief Executive Officer and Director
William B. Rutherford Executive Vice President and Chief Financial Officer
Jon Mack Foster Executive Vice President and Chief Operating Officer
Erol R. Akdamar FACHE President of American Group
Timothy M. McManus President of National Group
Dr. Thomas F. Frist Jr., M.D. Founder and Chairman Emeritus
Chad J. Wasserman Senior Vice President and Chief Information Officer
Michael R. McAlevey Executive Vice President and Chief Legal and Administrative Officer
Frank George Morgan C.F.A. Vice President of Investor Relations
Kathleen M. Whalen J.D. Senior Vice President and Chief Ethics and Compliance Officer

Latest SEC Filings

Date Type Title
Apr 5, 2024 PX14A6G Notice of exempt solicitation submitted by non-management
Mar 27, 2024 PX14A6G Notice of exempt solicitation submitted by non-management
Mar 20, 2024 144 Filing
Mar 18, 2024 144 Filing
Mar 15, 2024 ARS Filing
Mar 15, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 15, 2024 DEF 14A Other definitive proxy statements
Feb 26, 2024 8-K/A [Amend] Current report
Feb 26, 2024 8-K Current Report
Feb 23, 2024 8-K Current Report